Thomas Frisell

Sibling Comparison Designs

Thomas Frisell, Anna Sara Öberg, Ralf Kuja‐Halkola et al. · Epidemiology · 2012 · 551 citations

Public Health, Biostatistics, Causal Inference +12

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

Gustavo Luna, Peter Alping, Joachim Burman et al. · JAMA Neurology · 2019 · 509 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +10

Rituximab versus fingolimod after natalizumab in multiple sclerosis patients

Peter Alping, Thomas Frisell, Lenka Novakova et al. · Annals of Neurology · 2016 · 229 citations

Life Sciences, Neurology, Pharmacotherapy +16

Comparative Effectiveness of Rituximab and Other Initial Treatment Choices for Multiple Sclerosis

Mathias Granqvist, Malin Boremalm, Amyar Poorghobad et al. · JAMA Neurology · 2018 · 212 citations · Full text

Medicine, Neurology, Pharmacotherapy +13

Familial Risks and Heritability of Rheumatoid Arthritis: Role of Rheumatoid Factor/Anti–Citrullinated Protein Antibody Status, Number and Type of Affected Relatives, Sex, and Age

Thomas Frisell, Marie Holmqvist, Henrik Källberg et al. · Arthritis & Rheumatism · 2013 · 210 citations

Life Sciences, Genetics, Immunology +17